1. Adar, Y., Singer, Y., Levi, R., Tzehoval, E., Perk, S., Banet-Noach, C., Nagar, S., Arnon, R., and Ben-Yedidia, T. 2009. A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine
27, 2099–2107.
2. Alymova, I.V., Kodihalli, S., Govorkova, E.A., Fanget, B., Gerdil, C., and Webster, R.G. 1998. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs. J. Virol.
72, 4472–4477.
3. Angela, R.O. and Vetis, J. 2010. Recombinant newcastle disease virus expressing H5 hemagglutinin of avian influenza virus. US20100008945 A1.
4. Ångstrom, J., Miller-podraza, H., Pantzar, M., Karlsson, K., Blomqvist, M., Heiskanen, A., Niemela, R., Helin, J., Natunen, J., Satomaa, T., and Aitio, O. 2006. Peptide vaccine for influenza virus. WO2006111616 A1.
5. Anhlan, D., Scholtissek, C., and Ludwig, S. 2014. Live attenuated influenza virus. US20140302077 A1.